Will Companies Keep Retiree Drug Benefits?

Published On: April 29th, 2010

Medco told analysts that the “most likely choices for a large percentage” of companies was to stick with their current retiree drug plans or to switch over to a employer group waiver plan.

Read the rest here:
Will Companies Keep Retiree Drug Benefits?

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

Did you know:

Among adults, death rates for African Americans are approximately 55 percent higher than they are for whites

Health-Reform Update: White House Faults GOP, Rural Benefits
Here’s the sampling from this morning’s news on health reform: Obama special adviser David Axelrod doubts that two Republican senators involved in health-care talks aren’t negotiating seriously, reports the WSJ . “If you’re sitting at a table negotiating in good faith, then you probably don’t send out mailers saying, ‘Help me stop Obama-care.’ That’s just..
2011 Looks Tough For Drug Companies
AstraZeneca, Novartis, Eli Lilly and Bristol-Myers Squibb all reported earnings today. ..
Drug Companies’ Overseas Operations Cause Tax Headaches
After entering a $3.4 billion settlement with the Internal Revenue Service in late 2006, GlaxoSmithKline is again tangling with the tax man, with some $1.9 billion at stake. There’s nothing like digging into arcane tax issues right before a holiday weekend, so here goes. ..
Which Drug Companies Could Be Private-Equity Targets?
The recent $4 billion private-equity buyout of IMS Health raises an irresistible question: What other health-care companies might catch private equity’s eye? ..
Splitting the Medicare Drug Benefit’s Doughnut Hole
The $80 billion deal announced this weekend between drug makers and Washington Democrats points to one of the odder features of the Medicare Part D Drug Benefit: The doughnut hole. Medicare mavens and readers of a certain age will already be familiar with the hole — the gap in coverage that leaves beneficiaries on the..
Will Transparency Keep Heart Failure Patients Healthy?
If you go home from the hospital after being treated for congestive heart failure , there’s a good chance you’ll be back in a few weeks. ..

Orshe